多次注射钆基对比剂后大鼠中枢及周围神经系统的钆沉积及其对感觉、认知和运动能力的影响
研究将48只雄性Wistar大鼠随机分为钆双胺、钆喷酸葡胺、钆特酸葡胺和对照组,多次注射后评估中枢及周围神经系统的钆沉积及感觉、认知和运动影响。结果显示所有钆基对比剂均造成中枢和周围神经组织钆沉积,坐骨神经沉积最高(均值62.86 nmol/g,SD 12.56),钆双胺组出现痛觉过敏、肌力和空间认知功能下降。作者建议对疼痛高敏且需多次MRI检查的患者使用大环类对比剂并采用最低剂量。
要点
- 所有钆基对比剂均造成中枢和周围神经组织钆沉积,坐骨神经沉积最高(均值62.86 nmol/g,SD 12.56)。
- 钆双胺组出现痛觉过敏、肌力下降和空间认知功能受损。
- 脊髓内钆沉积呈「海胆样」球状结构,主要位于血管基底膜附近。
核心结论
- 多次注射钆基对比剂可造成脑、脊髓和周围神经的钆沉积,钆双胺组脊髓沉积最明显,并导致痛觉过敏、肌力下降和认知能力降低。
研究设计与样本
- 动物实验:48只6周龄雄性Wistar大鼠随机分为4组(每组12只),分别为钆双胺组(线性非离子型)、钆喷酸葡胺组(线性离子型)、钆特酸葡胺组(大环离子型)和对照组(0.9%氯化钠溶液),采用9.4T MRI扫描脑部,以电感耦合等离子体质谱测定钆沉积。
关键影像表现/征象
- 透射电镜显示脊髓内钆沉积区域呈类似「海胆」的球状结构,主要位于血管基底膜附近。
诊断标准与关键数值
- 所有钆基对比剂均造成中枢和周围神经组织钆沉积,坐骨神经组织沉积最高(均值62.86 nmol/g,SD 12.56)。
- 钆双胺组观察到肌力下降、空间认知功能受损以及对热和机械刺激的痛觉过敏。
临床应用与阅片要点
- 作者建议:对疼痛高敏且需多次MRI检查的患者,使用大环类钆基对比剂并采用最低剂量。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: After repeat administration of gadolinium-based contrast agents (GBCAs), the association between gadolinium retention in the central and peripheral nervous systems and the main manifestations of myelopathy and progressive neurologic symptoms remains unclear. We investigated the effects of the repeat administration of GBCAs on gadolinium retention in the central and peripheral nervous systems and the sensory, cognitive, and athletic implications.
MATERIALS AND METHODS: Forty-eight male Wistar rats (6 weeks of age) were randomly divided into 4 experimental groups (12 rats in each group): the gadodiamide group (linear and nonionic GBCAs), the gadopentetate dimeglumine group (linear and ionic GBCAs), the gadoterate meglumine group (macrocyclic and ionic GBCAs), and the control group (0.9% saline solution). The brains of the rats were scanned using 9.4T MRI. Sensory behavioral tests were performed to assess the effect of GBCAs on pain sensitivity function. Gadolinium deposition in the brain, spinal cord, and peripheral nerves was determined by inductively coupled plasma mass-spectrometry. Transmission electron microscopy was used to observe the microscopic distribution of gadolinium after deposition in the spinal cord. The histopathologic features in the spinal cord were analyzed by H&E staining, Nissl staining, glial fibrillary acidic protein staining, and neuron-specific enolase staining after administration of GBCAs.
RESULTS: All GBCAs resulted in gadolinium deposition in the central and peripheral nerve tissues, with the highest deposition in the sciatic nerve tissue (mean, 62.86 [SD, 12.56] nmol/g). Decreased muscle power, impairment of spatial cognitive function power, and pain hypersensitivity to thermal and mechanical stimuli were observed after exposure to gadodiamide. At the spinal cord, transmission electron microscopy found that the region of gadolinium depositions had a spheric structure similar to "sea urchins" and was mainly located near the vascular basement membrane.
CONCLUSIONS: Multiple injections of GBCAs caused gadolinium deposition in the brain, spinal cord, and peripheral nerves, especially in the spinal cords of the gadodiamide group. Gadodiamide led to pain hypersensitivity and decreased muscle power and cognitive ability. For the patients who are hypersensitive to pain and need multiple MRI examinations, we recommend using macrocyclic GBCAs and the lowest dose possible.
引用
- Yao X, Hu J, Wang G, et al. Deposition of Gadolinium in the Central and Peripheral Nervous Systems and Its Effects on Sensory, Cognitive, and Athletic Implications after Multiple Injections of Gadolinium-Based Contrast Agents in Rats. AJNR Am J Neuroradiol. 2024. PMID: 38991773. doi:10.3174/ajnr.A8295
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。